Literature DB >> 31559179

Delayed enhancement in differential diagnosis of salivary gland neoplasm.

Alfonso Reginelli1, Alfredo Clemente1, Matteo Renzulli2, Nicola Maggialetti3, Mario Santagata4, Giuseppe Colella4, Valerio Nardone5, Rita Golfieri2, Luca Brunese3, Salvatore Cappabianca1.   

Abstract

BACKGROUND: Multi-phasic Computed Tomography (CT) evaluation allows to study the enhancement features of parotid gland masses. The aim of our study was to evaluate the role of delayed enhancement in the characterization of different histologic types of parotid tumours.
METHODS: Forty-eight patients (22 male and 26 female) with at least one parotid gland tumor, were included in our study. Multi-phase CT images were obtained before and 30, 120 s and 8 minutes after intravenous contrast injection. The images were evaluated by two radiologists for lesion enhancement degree. A quantitative assessment was performed using a region of interest on each lesion and density changes between different phases were compared. The tumoral enhancement ratio was calculated between the 8 minutes delayed and the early (30 s) phase. The pathological diagnosis was confirmed in all patients after surgery.
RESULTS: All patients had unilateral lesion for a total of 48 lesions. Twenty-eight were pleomorphic adenomas, 15 Warthin's tumours and 5 carcinomas. All Warthin tumours showed a rapid contrast enhancement at the early phase (30 sec) followed by a progressive wash-out during the delayed scans. Most of pleomorphic adenomas (89.2%) showed the highest density at the 8-minutes delayed phase. Malignant tumours showed slower contrast enhancement and 3 out of 5 (60%) showed a marked decrease at the 8 minutes delayed phase while the remaining 2 (40%), did not show any density reduction. The tumoral enhancement ratio was significantly different between Warthin tumours and pleomorphic adenomas and between Warthin's and malignant tumours.
CONCLUSIONS: Multi-phasic CT examination with 8 minutes delayed acquisition has shown to be useful in parotid gland lesion differentiation.

Entities:  

Keywords:  Parotid gland; computed tomography; neoplasm

Year:  2019        PMID: 31559179      PMCID: PMC6755945          DOI: 10.21037/gs.2019.03.03

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  30 in total

1.  Comparison of computed tomography and magnetic resonance imaging in the diagnosis of parotid tumors.

Authors:  Mehmet Koyuncu; Teoman Seşen; Hüseyin Akan; Ahmet A Ismailoglu; Yücel Tanyeri; Atilla Tekat; Recep Unal; Lütfi Incesu
Journal:  Otolaryngol Head Neck Surg       Date:  2003-12       Impact factor: 3.497

2.  Parotid gland fine-needle aspiration cytology: an approach to differential diagnosis.

Authors:  Odile David; Saad Blaney; Matthew Hearp
Journal:  Diagn Cytopathol       Date:  2007-01       Impact factor: 1.582

3.  Salivary gland tumors: evaluation with two-phase helical CT.

Authors:  D S Choi; D G Na; H S Byun; Y H Ko; C K Kim; J M Cho; H K Lee
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

4.  Treatment of malignant neoplasms of the parotid gland.

Authors:  M Magnano; C F gervasio; L Cravero; G Machetta; W Lerda; G Beltramo; R Orecchia; R Ragona; M Bussi
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

5.  Incidence rates of salivary gland tumors: results from a population-based study.

Authors:  J A Pinkston; P Cole
Journal:  Otolaryngol Head Neck Surg       Date:  1999-06       Impact factor: 3.497

6.  Parotid masses: prediction of malignancy using magnetization transfer and MR imaging findings.

Authors:  S Takashima; J Wang; F Takayama; M Momose; T Matsushita; S Kawakami; A Saito; T Ishiyama
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

7.  Advantages of multidetector-row CT with multiplanar reformation in guiding percutaneous lung biopsies.

Authors:  M De Filippo; M Onniboni; M Rusca; P Carbognani; L Ferrari; A Guazzi; A Casalini; E Verardo; V Cataldi; M Tiseo; N Sverzellati; G Chiari; E Rabaiotti; A Corsi; G Cacciani; M Sommario; A Ardizzoni; M Zompatori
Journal:  Radiol Med       Date:  2008-09-25       Impact factor: 3.469

8.  Maxillofacial fibrous dysplasia: personal experience with gadoliniumenhanced magnetic resonance imaging.

Authors:  S Cappabianca; G Colella; A Russo; M Pezzullo; A Reginelli; F Iaselli; A Rotondo
Journal:  Radiol Med       Date:  2008-10-04       Impact factor: 3.469

9.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Dynamic multislice computed tomography findings for parotid gland tumors.

Authors:  Hasan Yerli; Erdinc Aydin; Mehmet Coskun; Elif Geyik; Levent N Ozluoglu; Nihan Haberal; Tolga Kaskati
Journal:  J Comput Assist Tomogr       Date:  2007 Mar-Apr       Impact factor: 1.826

View more
  3 in total

1.  Can the height of the parotid tumor be a predictor of malignancy?

Authors:  Gene Huh; Jae-Cheul Ahn; Wonjae Cha; Woo-Jin Jeong
Journal:  Gland Surg       Date:  2021-02

2.  Comparison of Different Machine Models Based on Multi-Phase Computed Tomography Radiomic Analysis to Differentiate Parotid Basal Cell Adenoma From Pleomorphic Adenoma.

Authors:  Yun-Lin Zheng; Yi-Neng Zheng; Chuan-Fei Li; Jue-Ni Gao; Xin-Yu Zhang; Xin-Yi Li; Di Zhou; Ming Wen
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

3.  The Clinical Characteristics and CT Findings of Parotid and Submandibular Gland Tumours.

Authors:  Houdong Zuo
Journal:  J Oncol       Date:  2021-07-03       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.